343 related articles for article (PubMed ID: 28615207)
21. Optimized binding of substituted quinoline ALLINIs within the HIV-1 integrase oligomer.
Sun J; Patel K; Hume J; Pigza JA; Donahue MG; Kessl JJ
J Biol Chem; 2021; 296():100363. PubMed ID: 33539919
[TBL] [Abstract][Full Text] [Related]
22. A Conformational Escape Reaction of HIV-1 against an Allosteric Integrase Inhibitor.
Nakamura T; Nakamura T; Amano M; Miyakawa T; Yamagata Y; Matsuoka M; Nakata H
J Virol; 2020 Sep; 94(19):. PubMed ID: 32611758
[TBL] [Abstract][Full Text] [Related]
23. Multifaceted HIV integrase functionalities and therapeutic strategies for their inhibition.
Engelman AN
J Biol Chem; 2019 Oct; 294(41):15137-15157. PubMed ID: 31467082
[TBL] [Abstract][Full Text] [Related]
24. HIV-1 capsid stability and reverse transcription are finely balanced to minimize sensing of reverse transcription products
Eschbach JE; Puray-Chavez M; Mohammed S; Wang Q; Xia M; Huang L-C; Shan L; Kutluay SB
mBio; 2024 May; 15(5):e0034824. PubMed ID: 38530034
[TBL] [Abstract][Full Text] [Related]
25. Interaction between Reverse Transcriptase and Integrase Is Required for Reverse Transcription during HIV-1 Replication.
Tekeste SS; Wilkinson TA; Weiner EM; Xu X; Miller JT; Le Grice SF; Clubb RT; Chow SA
J Virol; 2015 Dec; 89(23):12058-69. PubMed ID: 26401032
[TBL] [Abstract][Full Text] [Related]
26. INI1/hSNF5-interaction defective HIV-1 IN mutants exhibit impaired particle morphology, reverse transcription and integration in vivo.
Mathew S; Nguyen M; Wu X; Pal A; Shah VB; Prasad VR; Aiken C; Kalpana GV
Retrovirology; 2013 Jun; 10():66. PubMed ID: 23799881
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of HIV-1 Maturation via Small-Molecule Targeting of the Amino-Terminal Domain in the Viral Capsid Protein.
Wang W; Zhou J; Halambage UD; Jurado KA; Jamin AV; Wang Y; Engelman AN; Aiken C
J Virol; 2017 May; 91(9):. PubMed ID: 28202766
[TBL] [Abstract][Full Text] [Related]
28. HIV-1 uncoating by release of viral cDNA from capsid-like structures in the nucleus of infected cells.
Müller TG; Zila V; Peters K; Schifferdecker S; Stanic M; Lucic B; Laketa V; Lusic M; Müller B; Kräusslich HG
Elife; 2021 Apr; 10():. PubMed ID: 33904396
[TBL] [Abstract][Full Text] [Related]
29. A protein ballet around the viral genome orchestrated by HIV-1 reverse transcriptase leads to an architectural switch: from nucleocapsid-condensed RNA to Vpr-bridged DNA.
Lyonnais S; Gorelick RJ; Heniche-Boukhalfa F; Bouaziz S; Parissi V; Mouscadet JF; Restle T; Gatell JM; Le Cam E; Mirambeau G
Virus Res; 2013 Feb; 171(2):287-303. PubMed ID: 23017337
[TBL] [Abstract][Full Text] [Related]
30. Optimizing the Multimerization Properties of Quinoline-Based Allosteric HIV-1 Integrase Inhibitors.
Sun J; Kessl JJ
Viruses; 2024 Jan; 16(2):. PubMed ID: 38399977
[TBL] [Abstract][Full Text] [Related]
31. Discovery of a Distinct Chemical and Mechanistic Class of Allosteric HIV-1 Integrase Inhibitors with Antiretroviral Activity.
Burlein C; Wang C; Xu M; Bhatt T; Stahlhut M; Ou Y; Adam GC; Heath J; Klein DJ; Sanders J; Narayan K; Abeywickrema P; Heo MR; Carroll SS; Grobler JA; Sharma S; Diamond TL; Converso A; Krosky DJ
ACS Chem Biol; 2017 Nov; 12(11):2858-2865. PubMed ID: 29024587
[TBL] [Abstract][Full Text] [Related]
32. Requirement for integrase during reverse transcription of human immunodeficiency virus type 1 and the effect of cysteine mutations of integrase on its interactions with reverse transcriptase.
Zhu K; Dobard C; Chow SA
J Virol; 2004 May; 78(10):5045-55. PubMed ID: 15113886
[TBL] [Abstract][Full Text] [Related]
33. HIV-1 reverse transcriptase and integrase enzymes physically interact and inhibit each other.
Tasara T; Maga G; Hottiger MO; Hübscher U
FEBS Lett; 2001 Oct; 507(1):39-44. PubMed ID: 11682056
[TBL] [Abstract][Full Text] [Related]
34. HIV type 1 integrase inhibitors: from basic research to clinical implications.
Jegede O; Babu J; Di Santo R; McColl DJ; Weber J; Quiñones-Mateu M
AIDS Rev; 2008; 10(3):172-89. PubMed ID: 18820719
[TBL] [Abstract][Full Text] [Related]
35. Small-molecule inhibition of human immunodeficiency virus type 1 infection by virus capsid destabilization.
Shi J; Zhou J; Shah VB; Aiken C; Whitby K
J Virol; 2011 Jan; 85(1):542-9. PubMed ID: 20962083
[TBL] [Abstract][Full Text] [Related]
36. A new class of multimerization selective inhibitors of HIV-1 integrase.
Sharma A; Slaughter A; Jena N; Feng L; Kessl JJ; Fadel HJ; Malani N; Male F; Wu L; Poeschla E; Bushman FD; Fuchs JR; Kvaratskhelia M
PLoS Pathog; 2014 May; 10(5):e1004171. PubMed ID: 24874515
[TBL] [Abstract][Full Text] [Related]
37. Study on suitable analysis method for HIV-1 non-catalytic integrase inhibitor.
Park KH; Kim M; Bae SE; Lee HJ; Kim KC; Choi BS; Kim YB
Virol J; 2021 Jan; 18(1):17. PubMed ID: 33436020
[TBL] [Abstract][Full Text] [Related]
38. Emergence of Compensatory Mutations Reveals the Importance of Electrostatic Interactions between HIV-1 Integrase and Genomic RNA.
Shema Mugisha C; Dinh T; Kumar A; Tenneti K; Eschbach JE; Davis K; Gifford R; Kvaratskhelia M; Kutluay SB
mBio; 2022 Oct; 13(5):e0043122. PubMed ID: 35975921
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of the activities of reverse transcriptase and integrase of human immunodeficiency virus type-1 by peptides derived from the homologous viral protein R (Vpr).
Gleenberg IO; Herschhorn A; Hizi A
J Mol Biol; 2007 Jun; 369(5):1230-43. PubMed ID: 17490682
[TBL] [Abstract][Full Text] [Related]
40. An HIV-1 capsid binding protein TRIM11 accelerates viral uncoating.
Yuan T; Yao W; Tokunaga K; Yang R; Sun B
Retrovirology; 2016 Oct; 13(1):72. PubMed ID: 27737691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
